Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Cu/Ir synergistic catalysis for stereo-diverse tetrahydro-γ-carbolines. High yield, mild conditions, scalable pharmaceutical intermediate manufacturing.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN116813659A introduces a threonine-based chiral catalyst enabling high enantioselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Novel rhodium-catalyzed pathway enhances purity and yield for sitagliptin intermediates, offering significant supply chain stability and cost reduction potential.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Novel pyridine-amide-oxazoline ligands for asymmetric hydroboration. High yield synthesis over 80 percent. Reliable supplier for pharma intermediates.
Patent CN115108875A reveals a metal-free visible light asymmetric method for synthesizing nitrogen-containing chiral cyclic alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107382644B details a novel Pd-B co-catalyzed asymmetric method for chiral tertiary alcohols, offering high ee and mild conditions for antifungal drug manufacturing.
Patent CN1972898A details a novel Rh-catalyzed asymmetric hydrogenation process for unprotected beta-amino acids, offering significant cost reduction and streamlined API manufacturing.
Novel cobalt-catalyzed route offers high optical purity and scalable production for flavor and pharmaceutical intermediates.
Advanced synthesis of chiral succinic acid derivatives via titanium catalysis. Reliable pharmaceutical intermediate supplier offering cost-effective, scalable routes.
Patent CN1068876C details a novel route for chiral succinic acid derivatives, offering improved purity and yield for pharmaceutical intermediates.
Patent CN105879905B details a novel chiral phosphine catalyst enabling asymmetric RC reactions with high enantioselectivity, offering cost and supply advantages.
Patent CN1842533A discloses novel P,N-ligands enabling high-ee hydrogenation. Offers supply chain stability for chiral pharmaceutical intermediate manufacturing.
Patent CN104130187B details efficient asymmetric synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN107056796B details a novel copper-catalyzed synthesis route offering high stereoselectivity and simplified processing for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN1791607A details novel chiral ligands enabling high enantioselectivity. Discover cost-effective manufacturing and scalable supply solutions for pharmaceutical intermediates.
Patent CN101003549B discloses a robust synthesis of planar chiral [2.2]paracyclophane phosphines via cyclopalladium resolution, offering high stability for pharmaceutical intermediates.
Patent CN110734378B reveals a mild Ni-catalyzed method for high-ee chiral allylamines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.